Impaired glucose tolerance, impaired fasting glycaemia and cardiovascular risk
- PMID: 15673935
Impaired glucose tolerance, impaired fasting glycaemia and cardiovascular risk
Abstract
Type 2 Diabetes Mellitus tends to increase year by year and it has a high morbidity and mortality, especially among those who have macro-vascular complication(s) as cardiovascular disease. There are many prevention efforts that have been done, especially primary prevention i.e. prevention of Type 2 Diabetes Mellitus development. Impaired Glucose Tolerance (IGT) and Imparied Fasting Gycaemia (IFG) is regarded as a phase between individual with normal blood glucose and type 2 diabetes mellitus. Individual with Impaired Glucose Tolerance (IGT) has higher possibility to develop Diabetes Mellitus compared to Impaired Fasting Gycaemia (IFG). Likewise, it also has more important role to cause Cardio-Vascular Disease. IGT may develop Cardiovascular Disease similar to Diabetes Mellitus, hence either IGT or Type 2 Diabetes Mellitus is categorized as independent risk factor of Cardio-Vascular Disease development. If compared to IFG then frequency of IGT is more excessive in the population, so that 2 hrs blood glucose after 75 gram glucose load test should be done in blood glucose testing.
Similar articles
-
People with impaired glucose tolerance and impaired fasting glucose are similarly susceptible to cardiovascular disease: a study in first-degree relatives of type 2 diabetic patients.Ann Nutr Metab. 2010;56(4):267-72. doi: 10.1159/000294752. Epub 2010 Apr 22. Ann Nutr Metab. 2010. PMID: 20413967
-
Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab).Circulation. 2007 Jul 10;116(2):151-7. doi: 10.1161/CIRCULATIONAHA.106.685628. Epub 2007 Jun 18. Circulation. 2007. PMID: 17576864
-
Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.Acta Diabetol. 2008 Sep;45(3):151-6. doi: 10.1007/s00592-008-0034-y. Epub 2008 May 22. Acta Diabetol. 2008. PMID: 18496644
-
Glycaemic control is essential for effective cardiovascular risk reduction across the type 2 diabetes continuum.Ann Med. 2005;37(4):250-8. doi: 10.1080/07853890510037365. Ann Med. 2005. PMID: 16019723 Review.
-
Glucose and cardiovascular risk.Neth J Med. 2002 Jun;60(5):192-9. Neth J Med. 2002. PMID: 12365474 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical